Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): a status quo

Affiliations

¹ Department of Internal Medicine, Hematology and Oncology Division, American University of Beirut Medical Centre, Beirut, Lebanon. Electronic address: ataher@aub.edu.lb.
² Department of Internal Medicine, Hematology and Oncology Division, American University of Beirut Medical Centre, Beirut, Lebanon.
³ Division of Hematology and Oncology, Department of Pediatrics and Thalassemia Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
⁴ Department of Hematology, University College London, London, UK.
⁵ Department of Clinical Sciences and Community, University of Milan, IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.

Ali T Taher et al. Blood Cells Mol Dis. 2014 Feb-Mar.

. 2014 Feb-Mar;52(2-3):88-90.

doi: 10.1016/j.bcmd.2013.08.006. Epub 2013 Sep 13.

¹ Department of Internal Medicine, Hematology and Oncology Division, American University of Beirut Medical Centre, Beirut, Lebanon. Electronic address: ataher@aub.edu.lb.
² Department of Internal Medicine, Hematology and Oncology Division, American University of Beirut Medical Centre, Beirut, Lebanon.
³ Division of Hematology and Oncology, Department of Pediatrics and Thalassemia Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
⁴ Department of Hematology, University College London, London, UK.
⁵ Department of Clinical Sciences and Community, University of Milan, IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.

No abstract available

Publication types